REFERENCES
- Olivieri NF, Weatherall DJ. Clinical aspects of β-thalassemia and related disorders. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, Eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management, 2nd ed. Cambridge: Cambridge University Press. 2009:357–416.
- Taher AT, Isma'eel H, Cappellini MD. Thalassaemia intermedia: revisited. Blood Cells Mol Dis. 2006;37(1):12–20.
- Cappellini MD, Musallam KM, Taher AT. Insight onto the pathophysiology and clinical complications of thalassemia intermedia. Hemoglobin. 2009;33(Suppl. 1):S145–S159.
- Taher AT, Musallam KM, Karimi M, Overview on pratices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115(10):1886–1892.
- Joly P, Lacan P, Garcia C, Identification and molecular characterization of four new large deletions in the β-globin gene cluster. Blood Cells Mol Dis. 2009;43(1):53–57.
- Nguyen TKT, Joly P, Bardel C, The XmnI Gγ polymorphism influences Hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 β-thalassemia intermedia patients. Blood Cells Mol Dis. Retrieved online 15 May 2010.
- Harteveld CL, Voskamp A, Phylipsen M, Nine unknown rearrangements in 16p13.3 and 11p15.4 causing α- and β-thalassemia characterized by high resolution multiplex ligation-dependent probe amplification. J Med Genet 2005;42(12):922–931.
- Farber HW, Loscalzo J. Pulmonary arterial hypertension. New Engl J Med. 2004;351(16):1655–1665.
- Singer ST, Kuypers FA, Styles L, Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006;81(9):670–675.
- Simonneau G, Robbins IM, Beghetti M, Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(Suppl 1):S43–S54.
- Ziol M, Handra-Luca A, Kettaneh A, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41(1):48–54.
- Castéra L, Vergniol L, Foucher J, Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128(2):343–350.
- Fei YJ, Stoming TA, Efremov GD, β-Thalassemia due to a T>A mutation within the ATA box. Biochem Biophys Res Commun. 1988;153(2):741–747.
- Zertal-Zidani S, Ducrocq R, Weil-Olivier C, A novel δβ fusion gene expresses Hemoglobin A (HbA) not Hb Lepore: Senegalese δ0β+-thalassemia. Blood. 2001;98(4):1261–1263.